Skip to main content
SLU:s publikationsdatabas (SLUpub)

Forskningsartikel2014Vetenskapligt granskad

Thymidine kinase 1 is a better prognostic marker than Ki-67 for pT1 adenocarcinoma of the lung

Xu, Yan; Liu, Biao; Shi, Qun-Li; Huang, Pei-Lin; Zhou, Xiao-Jun; Ma, Heng-Hui; Lu, Zhen-Feng; Bo, Yu; Eriksson, Staffan; He, Ellen; Skog, Sven

Sammanfattning

Objectives: The sensitivity and reliability of the biomarkers thymidine kinase 1 (TK1) and Ki-67 were studied in relation to clinical features and prognosis of survival for pathological-T1 (pT1) lung adenocarcinoma patients. Methods: TK1 and Ki-67 expression was determined in 80 patients with pT1 adenocarcinoma of the lung and in 20 specimens from normal lung tissues, using immunohistochemistry. Results: TK1 was found in most lung tumor cells both in the cytoplasm and the nuclei. The positive labelling index (LI) for total TK1 was significantly higher than that for Ki-67. There was a significant correlation between the LI of total TK1 and lymph node metastasis, degree of tumor invasion and pathologic stages, which was not found for Ki-67. In addition, the overall 5-year survival of patients was statistically significant different between low and high levels of TK1 expression, but not in cases of Ki-67. A multivariate analysis revealed that expression of TK1, lymph node involvement and TNM pathology staging could serve as independent prognostic factors for the disease progression of pT1 lung adenocarcinoma patients. Conclusions: Compared with Ki-67, TK1 is a more reliable proliferation index in pT1 adenocarcinoma of lung, which can evaluate the invasion and the prognosis of tumor.

Nyckelord

Lung neoplasms; adenocarcinoma; pT1; thymidine kinase 1; TK1; Ki-67; survival

Publicerad i

International Journal of Clinical and Experimental Medicine
2014, Volym: 7, nummer: 8, sidor: 2120-2128
Utgivare: E-CENTURY PUBLISHING CORP

    Globala målen

    SDG3 Säkerställa hälsosamma liv och främja välbefinnande för alla i alla åldrar

    UKÄ forskningsämne

    Cancer och onkologi

    Permanent länk till denna sida (URI)

    https://res.slu.se/id/publ/67742